Long-term Toxicity Surprise With ADT for Prostate CancerLong-term Toxicity Surprise With ADT for Prostate Cancer
The first-ever study of the long-term adverse events associated with androgen-deprivation therapy (ADT) suggest that intermittent therapy is not less toxic than continuous therapy. Medscape Medical News
Source: Medscape Urology Headlines - Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Prostate Cancer | Study | Toxicology | Urology & Nephrology